RespireRx Pharmaceuticals Inc. Annual Interest Expense in USD from 2011 to 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
RespireRx Pharmaceuticals Inc. quarterly/annual Interest Expense history and growth rate from 2011 to 2022.
  • RespireRx Pharmaceuticals Inc. Interest Expense for the quarter ending September 30, 2023 was $73.4K, a 22.4% decline year-over-year.
  • RespireRx Pharmaceuticals Inc. Interest Expense for the twelve months ending September 30, 2023 was $436K, a 45.5% decline year-over-year.
  • RespireRx Pharmaceuticals Inc. annual Interest Expense for 2022 was $604K, a 16.7% decline from 2021.
  • RespireRx Pharmaceuticals Inc. annual Interest Expense for 2021 was $725K, a 32.8% increase from 2020.
  • RespireRx Pharmaceuticals Inc. annual Interest Expense for 2020 was $546K, a 34.8% increase from 2019.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Annual (USD)
Interest Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $604K -$121K -16.7% Jan 1, 2022 Dec 31, 2022 10-K 2023-04-17
2021 $725K +$179K +32.8% Jan 1, 2021 Dec 31, 2021 10-K 2023-04-17
2020 $546K +$141K +34.8% Jan 1, 2020 Dec 31, 2020 10-K 2022-04-15
2019 $405K +$268K +197% Jan 1, 2019 Dec 31, 2019 10-K 2021-04-15
2018 $136K +$34K +33.3% Jan 1, 2018 Dec 31, 2018 10-K 2020-04-14
2017 $102K -$484K -82.6% Jan 1, 2017 Dec 31, 2017 10-K 2019-04-16
2016 $586K -$316K -35% Jan 1, 2016 Dec 31, 2016 10-K 2018-04-17
2015 $903K +$785K +670% Jan 1, 2015 Dec 31, 2015 10-K 2017-03-31
2014 $117K +$61K +108% Jan 1, 2014 Dec 31, 2014 10-K 2016-03-29
2013 $56.3K -$141K -71.4% Jan 1, 2013 Dec 31, 2013 10-K 2015-03-30
2012 $197K +$193K +4801% Jan 1, 2012 Dec 31, 2012 10-K 2015-01-06
2011 $4.02K Jan 1, 2011 Dec 31, 2011 10-K 2014-10-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.